IP Library Patent Application 19251556
Patent Application
App. No. 19/251,556

POLYMERIC DYES WITH LINKER GROUPS COMPRISING DEOXYRIBOSE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/251,556
Abstract

Compounds useful as fluorescent or colored dyes are disclosed. The compounds have the following structure (I): or a stereoisomer, tautomer or salt thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , L 1a , L 1b , L 2 , L 3 , L 4 , L 5 , L 6 , L 7 , M 1 , M 2 , q, w, m and n are as defined herein. Methods associated with preparation and use of such compounds are also provided.

Claims (57)

1 . A compound having the following structure (Ia):

or a stereoisomer, salt or tautomer thereof, wherein:

M 1 is, at each occurrence, independently a moiety comprising an active drug moiety;

L 1a comprises, at each occurrence, independently a heteroarylene linker;

L 1b is, at each occurrence, a linker;

L 2 and L 3 are, at each occurrence, independently optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene or heteroalkynylene linkers;

L 4 is, at each occurrence, independently an alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene or heteroalkynylene linker;

R 1 and R 2 are each independently H, OH, SH, alkyl, alkoxy, alkylether, heteroalkyl, —OP(═R a )(R b )R c , Q, or L′;

R 4 is, at each occurrence, independently OH, SH, O − , S − , OR d or SR d ;

R 5 is, at each occurrence, independently oxo, thioxo or absent;

R a is O or S;

R b is OH, SH, O − , S − , OR d or SR d ;

R c is OH, SH, O − , S − , OR d , OL′, SR d , alkyl, alkoxy, heteroalkyl, heteroalkoxy, alkylether, alkoxyalkylether, phosphate, thiophosphate, phosphoalkyl, thiophosphoalkyl, phosphoalkylether or thiophosphoalkylether;

R a is a counter ion;

Q is, at each occurrence, independently a moiety comprising a sulfhydryl, disulfide, activated ester, isothiocyanate, azide, alkyne, alkene, diene, dienophile, acid halide, sulfonyl halide, phosphine, α-haloamide, biotin, amino or maleimide functional group;

L′ is, at each occurrence, independently comprises an alkylene or heteroalkylene linker covalently bonded to: Q, a targeting moiety selected from an antibody and a cell surface receptor antagonist, a solid support selected from a polymeric bead and a non-polymeric bead, or a nucleoside;

m is, at each occurrence, an integer of one or greater; and

n is an integer of one or greater.

2 - 7 . (canceled)

8 . The compound of claim 1 , wherein L 1a has one of the following structures:

9 . (canceled)

10 . The compound of claim 1 , wherein at least one occurrence of L 3 is an alkylene linker and at least one occurrence of L 4 comprises alkylene oxide.

11 - 19 . (canceled)

20 . The compound of claim 1 , wherein the compound has one of the following structures (Ib) or (Ic):

21 . The compound of claim 1 , wherein the compound has one of the following structures (Id) or (Ie):

wherein:

z is an integer from 1 to 100.

22 . The compound of claim 1 , wherein L 1b , at each occurrence, independently is a linker comprising an alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene, alkyleneheteroarylenealkylene, alkyleneheterocyclylenealkylene, alkylenecarbocyclylenealkylene, heteroalkyleneheteroarylenealkylene, heteroalkyleneheterocyclylenealkylene, heteroalkylenecarbocyclylenealkylene, heteroalkyleneheteroaryleneheteroalkylene, heteroalkyleneheterocyclyleneheteroalkylene, heteroalkylenecarbocyclyleneheteroalkylene, alkyleneheteroaryleneheteroalkylene, alkyleneheterocyclyleneheteroalkylene, alkylenecarbocyclyleneheteroalkylene, heteroarylene, heterocyclylene, carbocyclylene, alkyleneheteroarylene, alkyleneheterocyclylene, heteroarylenealkylene, alkylenecarbocyclylene, carbocyclylenealkylene, heteroalkyleneheteroarylene, heteroalkyleneheterocyclylene, heteroaryleneheteroalkylene, heteroalkylenecarbocyclylene, carbocyclyleneheteroalkylene or heteroatomic linker.

23 . The compound of claim 1 , wherein R 4 is, at each occurrence, independently OH, O − or OR d and R 5 is, at each occurrence, oxo.

24 - 26 . (canceled)

27 . The compound of claim 1 , wherein R 1 or R 2 is each independently —OP(═R a )(R b )R c .

28 . The compound of claim 27 , wherein R c is OL′, wherein L′ comprises a heteroalkylene linker to: Q, a targeting moiety, an analyte molecule, a solid support, a solid support residue or a nucleoside.

29 . (canceled)

30 . The compound of claim 289 , wherein L′ comprises an alkylene oxide or phosphodiester moiety, or combinations thereof.

31 . The compound of claim 30 , wherein L′ has the following structure:

wherein:

m″ and n″ are independently an integer from 1 to 10;

R c is H, an electron pair or a counter ion;

L″ is R e or a direct bond or comprises an alkylene linkage to: Q, a targeting moiety, an analyte molecule, a solid support, or a nucleoside.

32 . The compound of claim 31 , wherein the targeting moiety is an antibody or cell surface receptor antagonist.

33 . The compound of claim 1 , wherein R 1 or R 2 has one of the following structures:

34 . The compound of claim 1 , wherein R 1 has the following structure:

35 - 38 . (canceled)

39 . The compound of claim 1 , wherein Q is a moiety shaving one of the following structures;

wherein:

X is halo; and

EWG is an electron withdrawing group.

40 - 45 . (canceled)

46 . The compound of claim 1 , wherein n is an integer from 3 to 12.

47 - 66 . (canceled)

67 . A composition comprising the compound of claim 1 and one or more analyte molecules.

68 - 98 . (canceled)

99 . The composition of claim 1 , wherein L 2 is absent at each occurrence.

100 . The compound of claim 99 , wherein L 1b , at each occurrence, independently is a linker comprising a heteroalkylene, heteroalkylenecarbocyclylenealkylene, or carbocyclylene linker.

101 . The compound of claim 22 , wherein L 1b , at each occurrence, independently is a linker comprising a heteroalkylene, heteroalkylenecarbocyclylenealkylene, or carbocyclylene linker.

102 . The compound of claim 20 , wherein L 1b , at each occurrence, independently is a linker comprising a heteroalkylene, heteroalkylenecarbocyclylenealkylene, or carbocyclylene linker.

103 . The compound of claim 21 , wherein L 1b , at each occurrence, independently is a linker comprising a heteroalkylene, heteroalkylenecarbocyclylenealkylene, or carbocyclylene linker.